Refine by
Patient Enrollment Articles & Analysis
33 articles found
The results demonstrate that enoblituzumab can successfully induce the body's anti-cancer activity, showing favorable therapeutic efficacy and safety for patients with high-risk or very high-risk prostate cancer. B7-H3 is expressed in limited amounts in normal tissues but is highly expressed in various cancers, including prostate cancer cells. ...
REAL is a phase 2a open-label study to assess preliminary safety, tolerability, and effect on clinical outcomes as well as neurodegeneration biomarkers of BRAVYL in patients with ALS. The study will enroll approximately 20 patients, all of whom will be treated with BRAVYL for 24 weeks. ...
After screening 11,583 patients, the study enrolled 5,988 patients with symptomatic heart failure and preserved ejection fraction (EF > 40%). ...
DSTP3086S, a humanized IgG1 anti-steap1 monoclonal antibody related to MMAE, demonstrated safety and significant antitumor activity in a Phase I trial of 77 mCRPC patients. PSA decreased by 50% in 18% of patients, local radiation reaction occurred in 6% of patients, and transformation to benign cycle tumor cells <5 in 60% of ...
A potential limitation of composite scores is that patients can be enrolled having significantly different congestion profiles. While this reflects the reality of the diversity of the population of patient with ADHF, it has the potential to result in the enrollment of patients having different primary mechanisms ...
With the rising demand for improving patient safety in clinical trials, the adoption of patient-centric solutions is considered the best route to enhance data accuracy and experience automated workflows. This is where eCOA comes into play. In this blog post, we will find out how electronic clinical outcome assessments are helping the clinical trials industry handle the ever-growing list of ...
ByClinion
Study background The objective of this study is to demonstrate the ability of the inflatable Prone Supports (IPS) to lower the IAP of patients in the prone position. Whenever the patients’ position is changed to prone, the IAP is increased due to abdominal compression.1,2 It has been demonstrated previously that an increased IAP is linked to increased ...
The randomized phase 2 S1800A study enrolled 136 eligible patients with stage IV or recurrent non-small cell lung cancer. These patients had previously received ICI therapy. In all cases, the patients' tumors eventually became resistant to these drugs and grew or spread before the patients were ...
For the first time, heart failure patients can have full visibility of their hearts’ LA pressure and self-adjust their medication to stop further deterioration and avoid hospitalizations April 26, 2022 08:30 AM Eastern Daylight Time TEL AVIV, Israel–(BUSINESS WIRE)–Vectorious Medical Technologies Ltd., today announced that it has ...
The new features provide healthcare providers and care teams supporting patients with diabetes and related chronic conditions the information needed to properly bill CPT codes for remote patient monitoring (RPM) activities. This evolution of Population Health Analytics, a tool available in our Glooko platform that creates advanced filters on ...
ABILITY Diabetes Global (Randomized Comparison of Abluminus DES+ Sirolimus-Eluting Stents versus Everolimus-Eluting Stents in Coronary Artery Disease Patients with Diabetes Mellitus Global) started off with the index patient enrolment on 11th June 2020 in Italy (at the peak of the 1st wave of COVID-19 pandemic) by P.I. ...
We recently announced that we’ve enrolled the first patient in the first human efficacy trial in our company’s history — a significant milestone for us, and for the patients we hope to serve. ...
There’s been a huge emphasis on developing new treatments to improve survival in patients with cancer, but these trials have become a costly undertaking for sponsor companies. ...
This pivotal study (NCT04960202) enrolled 2,246 patients with COVID-19, 1,120 received Paxlovid and 1,126 received placebo. ...
These results provide evidence of long-term effectiveness and durability of restorative neurostimulation in patients with disabling CLBP, secondary to multifidus muscle dysfunction. ...
Clinical data for pDVA were obtained from the PROMISE I study, and — for scenario analyses — from the ALPS study.6,8 Conducted under an FDA investigational device exemption, that study was a prospective, multicenter, single-arm, early feasibility study of the LimFlow pDVA approach to treating no-option CLTI. The study enrolled 32 patients (mean age, ...
The FORTIFY study was initiated in 2017 with the purpose to evaluate the ability of CERAMENT G to improve the treatment outcomes for patients with open tibia fractures G-A II-IIIB. Last patients follow up took place in June 2021. The drop-out rate, defined as difference between enrolled and completed patients, was 29% and lost ...
Prospective, multicenter, randomized, crossover study. Chronic corneal edema patients were randomized to one of two arms. The first arm was fitted with the Therapeutic Hyper-CL™ lens while the second arm was fitted with a standard soft bandage contact lens. ...
In this study, we investigated the changes of liver stiffness by magnetic resonance elastogaraphy (MRE) during DAA therapy. A total of 308 patients were enrolled in the study. Liver stiffness was measured twice before and after DAA treatment using MRE and time-course change of liver stiffness was investigated. ...
In real time, a physician can remotely adjust the patient’s medication based on the data. The device is the subject of the VECTOR-HF study, which is designed to enroll 45 patients with chronic New York Heart Association heart failure class III, hospitalization for worsening heart failure, or elevated ambulatory B-type natriuretic peptide ...